Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Progressive Keratoconus: early-phase trial registry

1 of 2 indexed Progressive Keratoconus trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Progressive Keratoconus: 2 US clinical trials tracked, 1 recruiting.

Progressive Keratoconus is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Glaukos Corporation, running 1 of these trials.

Enrollment posture brief

Registry condition progressive-keratoconus

OPEN 1 | RECR 50% | LATE 0 | EARLY 2 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Progressive Keratoconus (thi…50%
Open-enrollment share among volume-matched conditions near Progressive Keratoconus

Progressive Keratoconus lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Progressive Keratoconus on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Progressive Keratoconus is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11Phase 21

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Progressive Keratoconus records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Sham comparator Procedure
1 trials
Corneal collagen Procedure
1 trials
Sham Treatment Combination
1 trials
NXL Energy 3 Combination
1 trials
NXL Energy 2 Combination
1 trials
NXL Energy 1 Combination
1 trials

US sites by state

Facility locations filed on Progressive Keratoconus trials. A trial with sites in several states counts in each.

Ohio 1 trials
New Jersey 1 trials
Georgia 1 trials
Alabama 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Progressive Keratoconus page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Progressive Keratoconus trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Glaukos Corporation sponsors the most Progressive Keratoconus trials on record, review their full trial history before evaluating a specific study. See Glaukos Corporation's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Progressive Keratoconus condition card totals 2 registered trials; most-linked intervention Sham comparator; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.